Skip to main content
Top
Published in: Breast Cancer Research and Treatment 2/2020

Open Access 01-07-2020 | Bronchial Asthma | Clinical trial

Predictive risk factors of complications in different breast reconstruction methods

Authors: J. S. Palve, T. H. Luukkaala, M. T. Kääriäinen

Published in: Breast Cancer Research and Treatment | Issue 2/2020

Login to get access

Abstract

Purpose

Women with different BMI, age and comorbidities seek for breast reconstruction. It is critical to understand the risk associated with each technique to ensure the most appropriate method and timing is used. Outcome after reconstructions have been studied, but consensus is lacking regarding predictive risk factors of complications. The authors present their experience of different autologous and alloplastic reconstructions with an emphasis on predictors of complications.

Methods

Prospectively maintained reconstruction database from 2008 to 2019 was reviewed. Factors associated with complications were identified using logistic regression, multinomial logistic regression and risk factor score to determine predictors of complications.

Results

A total of 850 breast reconstructions were performed in 793 women, including 447 DIEP, 283 LD, 12 TMG and 51 implant reconstructions. Complications included minor (n = 231, 29%), re-surgery requiring (n = 142, 18%) and medical complications (n = 7, 1%). Multivariable analysis showed that complications were associated independently with BMI > 30 (OR 1.59; 95% CI 1.05–2.39, p = 0.027), LD technique (OR 4.05; 95% CI 2.10–7.81, p < 0.001), asthma or chronic obstructive pulmonary disease (OR 2.77; 95% CI 1.50–5.12, p = 0.001) and immediate operation (OR 0.69; 95% CI 0.44–1.07, p = 0.099). Each factor contributed 1 point in the creation of a risk-scoring system. The overall complication rate was increased as the risk score increased (35%, 61%, 76% and 100% for 1, 2, 3 and 4 risk scores, respectively, p < 0.001).

Conclusions

The rate of complication can be predicted by a risk-scoring system. In increasing trend of patients with medical problems undergoing breast reconstruction, tailoring of preventive measures to patients’ risk factors and careful consideration of the best timing of reconstruction is mandatory to prevent complications and costs.
Literature
1.
go back to reference Yoon AP, Qi L, Brown DL et al (2018) Outcomes of immediate versus delayed breast reconstruction: results of a multicenter prospective study. Breast 37:72–79CrossRef Yoon AP, Qi L, Brown DL et al (2018) Outcomes of immediate versus delayed breast reconstruction: results of a multicenter prospective study. Breast 37:72–79CrossRef
2.
go back to reference Olsen MA, Nickel KB, Fox IK, Margenthaler JA, Wallace AE, Fraser VJ (2017) Comparison of wound complications after immediate, delayed, and secondary breast reconstruction procedures. JAMA Surg 152(9):e172338CrossRef Olsen MA, Nickel KB, Fox IK, Margenthaler JA, Wallace AE, Fraser VJ (2017) Comparison of wound complications after immediate, delayed, and secondary breast reconstruction procedures. JAMA Surg 152(9):e172338CrossRef
3.
go back to reference Eltahir Y, Werners LL, Dreise MM et al (2013) Quality-of-life outcomes between mastectomy alone and breast reconstruction: comparison of patient-reported Breast-Q and other health-related quality-of-life measures. Plast Reconstr Surg 132:201–209CrossRef Eltahir Y, Werners LL, Dreise MM et al (2013) Quality-of-life outcomes between mastectomy alone and breast reconstruction: comparison of patient-reported Breast-Q and other health-related quality-of-life measures. Plast Reconstr Surg 132:201–209CrossRef
4.
go back to reference Toyserkani NM, Jørgensen MG, Tabatabaeifar S, Damsgaard T, Sørensen JA (2020) Autologous versus implant-based breast reconstruction: a systematic review and meta-analysis of Breast-Q patient-reported outcomes. J Plast Reconstruct Aesthet Surg 73(2):278–285CrossRef Toyserkani NM, Jørgensen MG, Tabatabaeifar S, Damsgaard T, Sørensen JA (2020) Autologous versus implant-based breast reconstruction: a systematic review and meta-analysis of Breast-Q patient-reported outcomes. J Plast Reconstruct Aesthet Surg 73(2):278–285CrossRef
5.
go back to reference Eltahir Y, Werners LL, Dreise MM, Zeijlmans van Emmichoven IA, Werker PM, de Bock GH (2015) Which breast is the best? Successful autologous or alloplastic breast reconstruction: patient-reported quality-of-life outcomes. Plast Reconstr Surg 135:43–50CrossRef Eltahir Y, Werners LL, Dreise MM, Zeijlmans van Emmichoven IA, Werker PM, de Bock GH (2015) Which breast is the best? Successful autologous or alloplastic breast reconstruction: patient-reported quality-of-life outcomes. Plast Reconstr Surg 135:43–50CrossRef
6.
go back to reference Liu C, Zhuang Y, Momeni A et al (2014) Quality of life and patient satisfaction after microsurgical abdominal flap versus staged expander/implant breast reconstruction: a critical study of unilateral immediate breast reconstruction using patient-reported outcomes instrument BREAST-Q. Breast Cancer Res Treat 146:117–126CrossRef Liu C, Zhuang Y, Momeni A et al (2014) Quality of life and patient satisfaction after microsurgical abdominal flap versus staged expander/implant breast reconstruction: a critical study of unilateral immediate breast reconstruction using patient-reported outcomes instrument BREAST-Q. Breast Cancer Res Treat 146:117–126CrossRef
7.
go back to reference Chao LF, Patel KM, Chen SC et al (2014) Monitoring patient-centered outcomes through the progression of breast reconstruction: a multicentered prospective longitudinal evaluation. Breast Cancer Res Treat 146:299–308CrossRef Chao LF, Patel KM, Chen SC et al (2014) Monitoring patient-centered outcomes through the progression of breast reconstruction: a multicentered prospective longitudinal evaluation. Breast Cancer Res Treat 146:299–308CrossRef
8.
go back to reference Thorarinsson A, Fröjd V, Kölby L et al (2016) A retrospective review of the incidence of various complications in different delayed breast reconstruction methods. J Plast Surg Hand Surg 50:25–34CrossRef Thorarinsson A, Fröjd V, Kölby L et al (2016) A retrospective review of the incidence of various complications in different delayed breast reconstruction methods. J Plast Surg Hand Surg 50:25–34CrossRef
9.
go back to reference Dindo D, Demartines N, Clavien PA (2004) Classification of surgical complications. A new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240:205–213CrossRef Dindo D, Demartines N, Clavien PA (2004) Classification of surgical complications. A new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240:205–213CrossRef
10.
go back to reference Johns N, Fairbairn N, Trail M (2018) Autologous breast reconstruction using the immediately lipofilled extended latissimus dorsi flap. J Plast Reconstr Aesthet Surg 71:201–208CrossRef Johns N, Fairbairn N, Trail M (2018) Autologous breast reconstruction using the immediately lipofilled extended latissimus dorsi flap. J Plast Reconstr Aesthet Surg 71:201–208CrossRef
11.
go back to reference Collier W, van Boerum MS, Kim J, Kwok AC (2019) Are 30-day outcomes enough? Late infectious readmissions following prosthetic-based breast reconstruction. Plast Reconstr Surg 144:360–368CrossRef Collier W, van Boerum MS, Kim J, Kwok AC (2019) Are 30-day outcomes enough? Late infectious readmissions following prosthetic-based breast reconstruction. Plast Reconstr Surg 144:360–368CrossRef
12.
go back to reference Park JW, Jung JH, Jeon BJ, Mun GH, Bang SI, Pyon JK (2020) Complications after immediate 2-stage tissue expander/implant breast reconstruction. A deeper look at the second stage. Ann Plast Surg 84(6):638–643CrossRef Park JW, Jung JH, Jeon BJ, Mun GH, Bang SI, Pyon JK (2020) Complications after immediate 2-stage tissue expander/implant breast reconstruction. A deeper look at the second stage. Ann Plast Surg 84(6):638–643CrossRef
13.
go back to reference Park JW, Lee KT, Jeon BJ et al (2019) Effects of antihypertensive drugs on outcomes of breast reconstruction. Ann Surg Oncol 26:1712–1719CrossRef Park JW, Lee KT, Jeon BJ et al (2019) Effects of antihypertensive drugs on outcomes of breast reconstruction. Ann Surg Oncol 26:1712–1719CrossRef
14.
go back to reference Seidenstuecker K, Munder B, Mahajan AL, Richrath P, Behrendt P, Andree C (2011) Morbidity of microsurgical breast reconstruction in patients with comorbid conditions. Plast Reconstr Surg 127:1086–1092CrossRef Seidenstuecker K, Munder B, Mahajan AL, Richrath P, Behrendt P, Andree C (2011) Morbidity of microsurgical breast reconstruction in patients with comorbid conditions. Plast Reconstr Surg 127:1086–1092CrossRef
15.
go back to reference Lipa JE, Youssef AA, Kuerer HM, Robb G, Chang DW (2003) Breast reconstruction in older women: advantages of autogenous tissue. Plast Reconstr Surg 111:1110–1121CrossRef Lipa JE, Youssef AA, Kuerer HM, Robb G, Chang DW (2003) Breast reconstruction in older women: advantages of autogenous tissue. Plast Reconstr Surg 111:1110–1121CrossRef
16.
go back to reference Depypere B, Herregods S, Denolf J (2019) 20 years of DIEAP flap breast reconstruction: a big data analysis. Sci Rep 9:12899CrossRef Depypere B, Herregods S, Denolf J (2019) 20 years of DIEAP flap breast reconstruction: a big data analysis. Sci Rep 9:12899CrossRef
17.
go back to reference Jonczyk MM, Jean J, Graham R, Chatterjee A (2019) Trending towards safer breast cancer surgeries? Examining acute complication rates from A 13-year NSQIP analysis. Cancers 11:253–270CrossRef Jonczyk MM, Jean J, Graham R, Chatterjee A (2019) Trending towards safer breast cancer surgeries? Examining acute complication rates from A 13-year NSQIP analysis. Cancers 11:253–270CrossRef
19.
go back to reference Masoomi H, Fairchild B, Marques ES (2019) Frequency and predictors of 30-day surgical site complications in autologous breast reconstruction surgery. World J Plast Surg 2:200–207 Masoomi H, Fairchild B, Marques ES (2019) Frequency and predictors of 30-day surgical site complications in autologous breast reconstruction surgery. World J Plast Surg 2:200–207
20.
go back to reference Fischer JP, Sieber B, Nelson JA et al (2013) Comprehensive outcome and cost analysis of free tissue transfer for breast reconstruction: an experience with 1303 flaps. Plast Reconstr Surg 131:195–203CrossRef Fischer JP, Sieber B, Nelson JA et al (2013) Comprehensive outcome and cost analysis of free tissue transfer for breast reconstruction: an experience with 1303 flaps. Plast Reconstr Surg 131:195–203CrossRef
21.
go back to reference Beugels J, Bod L, van Kuijk SM et al (2018) Complications following immediate compared to delayed deep inferior epigastric artery perforator flap breast reconstructions. Breast Cancer Res Treat 169:349–357CrossRef Beugels J, Bod L, van Kuijk SM et al (2018) Complications following immediate compared to delayed deep inferior epigastric artery perforator flap breast reconstructions. Breast Cancer Res Treat 169:349–357CrossRef
22.
go back to reference Evans GR, Schusterman MA, Kroll SS et al (1995) Reconstruction and the radiated breast: is there a role for implants? Plast Reconstr Surg 96:1111–1115CrossRef Evans GR, Schusterman MA, Kroll SS et al (1995) Reconstruction and the radiated breast: is there a role for implants? Plast Reconstr Surg 96:1111–1115CrossRef
23.
go back to reference Tran NV, Chang DW, Gupta A, Kroll SS, Robb GL (2001) Comparison of immediate and delayed free TRAM flap breast reconstruction in patients receiving postmastectomy radiation therapy. Plast Reconstr Surg 108:78–82CrossRef Tran NV, Chang DW, Gupta A, Kroll SS, Robb GL (2001) Comparison of immediate and delayed free TRAM flap breast reconstruction in patients receiving postmastectomy radiation therapy. Plast Reconstr Surg 108:78–82CrossRef
24.
go back to reference Klement KA, Hijawi JB, LoGiudice JA, Alghoul M, Omesiete-Adejare P (2016) Microsurgical Breast reconstruction in the obese: a better option than tissue expander/implant reconstruction? Plast Reconstr Surg 144:539–546CrossRef Klement KA, Hijawi JB, LoGiudice JA, Alghoul M, Omesiete-Adejare P (2016) Microsurgical Breast reconstruction in the obese: a better option than tissue expander/implant reconstruction? Plast Reconstr Surg 144:539–546CrossRef
25.
go back to reference Chang EI, Chang EI, Soto-Miranda MA et al (2015) Evolution of bilateral free flap breast reconstruction over 10 years: optimizing outcomes and comparison to unilateral reconstruction. Plast Reconstr Surg 135:946–953CrossRef Chang EI, Chang EI, Soto-Miranda MA et al (2015) Evolution of bilateral free flap breast reconstruction over 10 years: optimizing outcomes and comparison to unilateral reconstruction. Plast Reconstr Surg 135:946–953CrossRef
27.
go back to reference Muller-Sloof E, de Laat HEW, Hummelink SLM, Peters JWB, Ulrich DJO (2018) The effect of postoperative closed incision negative pressure therapy on the incidence of donor site wound dehiscence in breast reconstruction patients: dehiscence PREvention Study (DEPRES), pilot randomized controlled trial. J Tissue Viability 27:262–266CrossRef Muller-Sloof E, de Laat HEW, Hummelink SLM, Peters JWB, Ulrich DJO (2018) The effect of postoperative closed incision negative pressure therapy on the incidence of donor site wound dehiscence in breast reconstruction patients: dehiscence PREvention Study (DEPRES), pilot randomized controlled trial. J Tissue Viability 27:262–266CrossRef
Metadata
Title
Predictive risk factors of complications in different breast reconstruction methods
Authors
J. S. Palve
T. H. Luukkaala
M. T. Kääriäinen
Publication date
01-07-2020
Publisher
Springer US
Published in
Breast Cancer Research and Treatment / Issue 2/2020
Print ISSN: 0167-6806
Electronic ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-020-05705-3

Other articles of this Issue 2/2020

Breast Cancer Research and Treatment 2/2020 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine